Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN
Open Access
- 29 January 2022
- journal article
- letter
- Published by Elsevier in Oral Oncology
- Vol. 126, 105733
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe
- BMS
This publication has 21 references indexed in Scilit:
- Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation TechniquesJAMA Oncology, 2017
- The development of a liquid biopsy for head and neck cancersOral Oncology, 2016
- Recurrent head and neck cancer: United Kingdom National Multidisciplinary GuidelinesThe Journal of Laryngology & Otology, 2016
- PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerNew England Journal of Medicine, 2016
- Paired Box 5 Methylation Detection by Droplet Digital PCR for Ultra-Sensitive Deep Surgical Margins Analysis of Head and Neck Squamous Cell CarcinomaCancer Prevention Research, 2015
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNAPLOS ONE, 2015
- Epidemiology of Head and Neck CancerSurgical Oncology Clinics of North America, 2015
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Head and neck cancerThe Lancet, 2008
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2004